Mechanisms of severe acute intermittent hypoxia-induced phrenic long-term facilitation

Nicole L Nichols1, Gordon S Mitchell1

  • 1Department of Comparative Biosciences, University of Wisconsin, Madison, Wisconsin.

Journal of Neurophysiology
|February 10, 2021
PubMed

Insights

Severe acute intermittent hypoxia (sAIH) activates phrenic long-term facilitation (pLTF) through EPAC and PI3K/Akt pathways, distinct from moderate AIH. Surprisingly, sAIH-induced pLTF also involves MEK/ERK activity and is reduced by PKA inhibition.

Area of Science:

  • Neuroscience
  • Respiratory Physiology

Background:

  • Moderate acute intermittent hypoxia (mAIH) elicits phrenic long-term facilitation (pLTF) via Gq-coupled serotonin 2 receptors, MEK/ERK, and NADPH oxidase, constrained by cAMP-PKA.
  • Severe AIH (sAIH) elicits pLTF through Gs-coupled adenosine 2A receptors.
  • Serotonin 7 receptors activate phrenic motor facilitation (pMF) via EPAC and PI3K/Akt, constrained by NADPH oxidase.

Purpose of the Study:

  • To test if sAIH-induced pLTF utilizes the same downstream signaling as serotonin 7 receptor-induced pMF.
  • To investigate the signaling mechanisms underlying sAIH-induced pLTF.

Main Methods:

  • Anesthetized rats underwent sAIH exposure.
  • Intrathecal injections of inhibitors for EPAC (ESI-05), MEK/ERK (UO126), PKA (KT-5720), PI3K/Akt (PI828), and NADPH oxidase (apocynin) were administered.
  • sAIH-induced pLTF was measured and compared across inhibitor groups.

Main Results:

  • sAIH-induced pLTF was abolished by EPAC and PI3K/Akt inhibitors (ESI-05, PI828).
  • sAIH-induced pLTF was unexpectedly abolished by MEK/ERK inhibition (UO126) and attenuated by PKA inhibition (KT-5720).
  • NADPH oxidase inhibition marginally enhanced sAIH-induced pLTF.

Conclusions:

  • sAIH-induced pLTF involves EPAC and PI3K/Akt, differing from mAIH-induced pLTF.
  • The findings suggest sAIH-induced pLTF mechanisms share elements of both Gq and Gs pathways, indicating complex cross-talk.
  • Distinct signaling pathways underlie pLTF induced by moderate versus severe AIH.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
730
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
517
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
5.0K
Physiology of Respiration II: Neurogenic Control of Respiration01:22

Physiology of Respiration II: Neurogenic Control of Respiration

The neurogenic control of respiration coordinates various neural networks and pathways to regulate breathing rate and depth, meeting the body's oxygen and carbon dioxide exchange requirements. This system adapts to physiological and environmental conditions, ensuring optimal breathing patterns.
Central Control
The brainstem is the primary site of central control, hosting respiratory centers:
1.4K
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.8K
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
1.2K